More safe syringe sites needed to reduce infections from injecting drugs, study says – New Jersey Monitor

Expanding the number of locations in New Jersey where people can access clean syringes and dispose of used ones would lower the dangers of drug use, harm reduction advocates say. (Photo by Spencer Platt/Getty Images)
A new study finds that skin and soft tissue infections from drug injections resulted in thousands of hospitalizations, killed hundreds of people, and cost more than $1 billion in hospital charges in New Jersey in 2019.
Researchers with the New Jersey Harm Reduction Coalition said their findings show why it’s important for the state to expand safe syringe sites statewide. There are only seven around the state now.
“We should be fully funding and implementing accessible syringe programs in every corner of the Garden State,” said Michael Enich, the report’s primary author and a coalition trustee.
State officials should also report injection-related infection data, which is as important a measure of public health as the data on overdose fatalities, substance use treatment, viral hepatitis, and Narcan administrations the Department of Health now publicly reports, Enich added.
A state Department of Health spokeswoman did not respond to a request for comment.
The study finds:
Dr. Amesika Nyaku, one of the report’s authors, is an assistant professor of infectious diseases at Rutgers New Jersey Medical School.
“It is crucial for us to not only have transparency as we’re looking at the numbers and trends moving forward in New Jersey, but also have a keen eye to closing these disparities, because there should not be these differential outcomes according to people’s income, according to their race and ethnicity, according to gender, or according to their age,” Nyaku said.
Jenna Mellor, the coalition’s executive director, applauded measures now before legislators that would expand harm reduction services. Those include a bill that would allocate $15 million to expand access to safe needle programs, another that would decriminalize syringe possession, and another that would require pharmacies to sell syringes to adult customers without a prescription.
But she and other coalition members also called on policymakers to decriminalize drug possession and use, because people are less likely to seek treatment when addiction is treated as a crime rather than a chronic health condition.
Health care providers — especially first responders and emergency providers — should get more training to reduce the stigma associated with drug use, which also dissuades users from seeking help, coalition members said. They recommended that hospitals offer medication-assisted addiction treatment and connect patients with safe syringe services.
Because getting rid of needles altogether would eliminate the threat of infections from injecting drugs, the coalition also urged policymakers to provide funding for harm reduction programs to provide supplies to drug users who smoke or snort drugs, supplies like straws for one-time use, sterile razors, alcohol prep pads, and new pipes and filters.
“These infections are preventable, and by thinking meaningfully about how we can ensure a safe supply of sterile syringes, we can make sure that no other New Jerseyan dies of a severe bacterial infection,” Enich said.

GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX


GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
by Dana DiFilippo, New Jersey Monitor
November 3, 2022
by Dana DiFilippo, New Jersey Monitor
November 3, 2022
A new study finds that skin and soft tissue infections from drug injections resulted in thousands of hospitalizations, killed hundreds of people, and cost more than $1 billion in hospital charges in New Jersey in 2019.
Researchers with the New Jersey Harm Reduction Coalition said their findings show why it’s important for the state to expand safe syringe sites statewide. There are only seven around the state now.
“We should be fully funding and implementing accessible syringe programs in every corner of the Garden State,” said Michael Enich, the report’s primary author and a coalition trustee.
State officials should also report injection-related infection data, which is as important a measure of public health as the data on overdose fatalities, substance use treatment, viral hepatitis, and Narcan administrations the Department of Health now publicly reports, Enich added.
A state Department of Health spokeswoman did not respond to a request for comment.
The study finds:
Dr. Amesika Nyaku, one of the report’s authors, is an assistant professor of infectious diseases at Rutgers New Jersey Medical School.
“It is crucial for us to not only have transparency as we’re looking at the numbers and trends moving forward in New Jersey, but also have a keen eye to closing these disparities, because there should not be these differential outcomes according to people’s income, according to their race and ethnicity, according to gender, or according to their age,” Nyaku said.
Jenna Mellor, the coalition’s executive director, applauded measures now before legislators that would expand harm reduction services. Those include a bill that would allocate $15 million to expand access to safe needle programs, another that would decriminalize syringe possession, and another that would require pharmacies to sell syringes to adult customers without a prescription.
But she and other coalition members also called on policymakers to decriminalize drug possession and use, because people are less likely to seek treatment when addiction is treated as a crime rather than a chronic health condition.
Health care providers — especially first responders and emergency providers — should get more training to reduce the stigma associated with drug use, which also dissuades users from seeking help, coalition members said. They recommended that hospitals offer medication-assisted addiction treatment and connect patients with safe syringe services.
Because getting rid of needles altogether would eliminate the threat of infections from injecting drugs, the coalition also urged policymakers to provide funding for harm reduction programs to provide supplies to drug users who smoke or snort drugs, supplies like straws for one-time use, sterile razors, alcohol prep pads, and new pipes and filters.
“These infections are preventable, and by thinking meaningfully about how we can ensure a safe supply of sterile syringes, we can make sure that no other New Jerseyan dies of a severe bacterial infection,” Enich said.

GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX

SUBSCRIBE


GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
New Jersey Monitor is part of States Newsroom, a network of news bureaus supported by grants and a coalition of donors as a 501c(3) public charity. New Jersey Monitor maintains editorial independence. Contact Editor Terrence McDonald for questions: info@newjerseymonitor.com. Follow New Jersey Monitor on Facebook and Twitter.
Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site. Please see our republishing guidelines for use of photos and graphics.
Dana DiFilippo comes to the New Jersey Monitor from WHYY, Philadelphia’s NPR station, and the Philadelphia Daily News, a paper known for exposing corruption and holding public officials accountable. Prior to that, she worked at newspapers in Cincinnati, Pittsburgh, and suburban Philadelphia and has freelanced for various local and national magazines, newspapers and websites. She lives in Central Jersey with her husband, a photojournalist, and their two children.
DEMOCRACY TOOLKIT
© New Jersey Monitor, 2022
New Jersey Monitor provides fair and tough reporting on the issues affecting New Jersey, from political corruption to education to criminal and social justice. We strive to hold powerful people accountable and explain how their actions affect New Jerseyans from Montague to Cape May.
DEIJ Policy | Ethics Policy | Privacy Policy
Our stories may be republished online or in print under Creative Commons licence CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site.

source

Add a Comment

Your email address will not be published. Required fields are marked *